enow.com Web Search

Search results

    25.99-0.55 (-2.07%)

    at Tue, May 28, 2024, 4:00PM EDT - U.S. markets open in 9 hours 27 minutes

    Nasdaq Real Time Price

    • Open 26.67
    • High 26.67
    • Low 25.93
    • Prev. Close 26.54
    • 52 Wk. High 32.00
    • 52 Wk. Low 13.97
    • P/E N/A
    • Mkt. Cap 1.3B
  1. Results from the WOW.Com Content Network
  2. Prism cover test - Wikipedia

    en.wikipedia.org/wiki/Prism_Cover_Test

    Either BASE IN for an exodeviation (eye turned out), BASE OUT for an esodeviation (eye turned in), BASE UP for a hypodeviation (eye turned down) or BASE DOWN for a hyperdeviation (eye turned up). Steps: 1. The patient should be measured in primary position first and then in any other positions of gaze of concern.

  3. Fixation disparity - Wikipedia

    en.wikipedia.org/wiki/Fixation_disparity

    This x-intercept is also referred to as aligning prism or – in earlier times – as associated phoria when the subjective nonius method was used (sP 0) the slope of the curve near zero prism load; Fig. 3: Fixation disparity as a function of the forced vergence angle which is induced by base-in prisms and base-out prisms in front of the eyes.

  4. Maddox rod - Wikipedia

    en.wikipedia.org/wiki/Maddox_rod

    If the patient saw a red line to the left and white light to the right, they are said to have exotropia or exophoria (crossed diplopia) in which base in(BI) prisms of increasing strength are used until the lines are superimposed.

  5. Prism fusion range - Wikipedia

    en.wikipedia.org/wiki/Prism_fusion_range

    From left to right: an accommodative fixation stick, a vertical prism bar, and a horizontal prism bar. The PFR involves placing a prism bar in front of an eye. In a patient with BSV, a natural shift of the eye occurs. When measuring horizontal fusion ranges, base in prisms assess fusional divergence while base out prisms assess fusional ...

  6. Pain ladder - Wikipedia

    en.wikipedia.org/wiki/Pain_ladder

    Pain ladder. "Pain ladder", or analgesic ladder, was created by the World Health Organization (WHO) as a guideline for the use of drugs in the management of pain. Originally published in 1986 for the management of cancer pain, it is now widely used by medical professionals for the management of all types of pain .

  7. Chronic progressive external ophthalmoplegia - Wikipedia

    en.wikipedia.org/wiki/Chronic_progressive...

    Chronic progressive external ophthalmoplegia ( CPEO) is a type of eye disorder characterized by slowly progressive inability to move the eyes and eyebrows. [1] It is often the only feature of mitochondrial disease, in which case the term CPEO may be given as the diagnosis. In other people suffering from mitochondrial disease, CPEO occurs as ...

  8. US FDA panel to discuss first psychedelic-assisted PTSD ... - AOL

    www.aol.com/news/us-fda-panel-discuss-first...

    Show comments. (Reuters) -The U.S. FDA's panel of independent advisers will on June 4 deliberate whether they should recommend approval for the first MDMA-assisted therapy for post-traumatic ...

  9. Worth 4 dot test - Wikipedia

    en.wikipedia.org/wiki/Worth_4_dot_test

    It can be used to establish whether a patient has the ability for the eyes to fuse the light that is received from each eye into 4 lights. The test is indicated with the use of a presence of a prism in individuals with a strabismus and fusion is considered present if 4 lights are maintained, with or without the use of a prism. The W4LT can also ...

  10. Hims & Hers Health says it will offer compounded GLP-1 ... - AOL

    www.aol.com/news/hims-hers-health-says-offer...

    The company’s oral medication kits start at $79 a month, and its compounded GLP-1 injections will start at $199 a month. Even before it added compounded GLP-1s to its portfolio, Hims & Hers said ...

  11. Ziconotide - Wikipedia

    en.wikipedia.org/wiki/Ziconotide

    Ziconotide, sold under the brand name Prialt, also called intrathecal ziconotide (ITZ) because of its administration route, is an atypical analgesic agent for the amelioration of severe and chronic pain. Derived from Conus magus, a cone snail, it is the synthetic form of an ω- conotoxin peptide. [1]